28 Mar 2026
On March 28, 2026, ASI Global inaugurated the new season of the LUMINAI Public Lecture Series with a keynote lecture, A Tale of Two Callings, delivered by Dr. Robert J. Lefkowitz, 2012 Nobel Laureate in Chemistry and James B. Duke Distinguished Professor at Duke University. The lecture set the tone for the 2026 season’s newly launched Nobel Laureates Special Series, an initiative designed to connect students with leading scientists and offer insights into their research journeys as well as their perspectives on the future of education and humanity in the age of artificial intelligence.
Approximately one thousand students from universities across the globe joined the lecture via livestream and interactive platforms, which marks the opening of the series’ fourth year and reaffirms ASI Global’s enduring commitment to expanding access to high-level academic dialogue and fostering the next generation of globally minded scientific talent.
Lecture Topic: A Tale of Two Callings
Titled A Tale of Two Callings, Professor Lefkowitz’s talk took a distinctive approach, blending scientific insight with personal reflection. Rather than focusing solely on research achievements, he traced the evolution of his career across two deeply felt “callings”. He recalled how an early fascination with a family doctor inspired his first calling—to become a physician. Years later, an unexpected research assignment at the National Institutes of Health led him to discover a second calling in scientific research. This transition was not without difficulty; he openly shared his initial struggles and failures in the laboratory, emphasizing that persistence and resilience are essential to any meaningful scientific pursuit.
Professor Lefkowitz Recalling His Research Journey
The Discovery and Impact of GPCRs
Professor Lefkowitz’s perseverance ultimately led to the discovery and characterization of G protein–coupled receptors (GPCRs), a breakthrough that has had a lasting impact on modern pharmacology. Today, GPCRs represent the largest family of receptors in the human genome and serve as targets for approximately one-third of all approved therapeutic drugs, underscoring their central role in contemporary medicine.
Keys to Success in Science
Recalling his scientific journey, Professor Lefkowitz offered a compelling reflection on what it takes to succeed in scientific research and in life. He highlighted several key principles: sustained focus, intellectual curiosity, willingness to take risks, and the ability to learn from failure. He encouraged students to pursue meaningful scientific questions rather than becoming overly attached to specific techniques, and to remain bold in the face of uncertainty. He also underscored the importance of mentorship, noting that guidance from experienced researchers can profoundly shape one’s career trajectory.
The lecture concluded with an inspiring Q&A session, during which students engaged with topics ranging from recent advances in GPCR research to the broader implications of artificial intelligence for science. Professor Lefkowitz discussed the concept of “biased signaling”, highlighting how different drugs acting on the same receptor can produce distinct biological effects. He also acknowledged the growing role of AI in accelerating discovery, particularly in areas such as protein structure prediction, while raising important questions about its ability to replicate human judgment in clinical and research contexts.
If you’re interested in learning more about the LUMINAI series, please feel free to contact us at publicity@gecacademy.com.